Non-gastrointestinal stromal tumours soft tissue sarcomas: an update

Soft tissue sarcomas (STS) encompass a diverse family of neoplasms of mesenchymal origin, marked by significant heterogeneity in terms of physiopathology, molecular characterisation, natural history and response to different therapies. This review aims to summarise the current strategies for the man...

Full description

Saved in:
Bibliographic Details
Published inEcancermedicalscience Vol. 13; p. 958
Main Author Duarte Ramos Matos, Gustavo
Format Journal Article
LanguageEnglish
Published Bristol Cancer Intelligence 13.08.2019
Subjects
Cancer therapies
Chemotherapy
Disease
Gastrointestinal cancer
Immunotherapy
Lymphatic system
Lymphedema
Lymphoma
Mastectomy
Metastasis
Mutation
NMR
Nuclear magnetic resonance
Radiation therapy
Review
Sarcoma
Surgeons
Tumors
Brazil
Online AccessGet full text

Cover

More Information
Summary:Soft tissue sarcomas (STS) encompass a diverse family of neoplasms of mesenchymal origin, marked by significant heterogeneity in terms of physiopathology, molecular characterisation, natural history and response to different therapies. This review aims to summarise the current strategies for the management of patients with STS, including surgery, systemic treatments and radiation therapy, along with considerations applicable to the most frequent subtypes, as well as particularities associated with less common and specific histologies. It also provides insights into upcoming strategies to tackle this challenging group of diseases.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:1754-6605
1754-6605
DOI:10.3332/ecancer.2019.958